|
HSP90B1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.12720010681767E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05209999995615E-06 |
| Normal-vs-Stage2 |
9.192300E-04 |
| Normal-vs-Stage3 |
6.53730000022001E-07 |
| Normal-vs-Stage4 |
4.41569999454217E-08 |
| Stage1-vs-Stage2 |
3.705800E-01 |
| Stage1-vs-Stage3 |
3.984200E-02 |
| Stage1-vs-Stage4 |
4.001500E-03 |
| Stage2-vs-Stage3 |
5.365000E-01 |
| Stage2-vs-Stage4 |
1.885650E-01 |
| Stage3-vs-Stage4 |
4.426400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.95379951001473E-10 |
| Normal-vs-AfricanAmerican |
3.236300E-02 |
| Normal-vs-Asian |
1.132240E-01 |
| Caucasian-vs-AfricanAmerican |
5.679600E-02 |
| Caucasian-vs-Asian |
5.795000E-01 |
| AfricanAmerican-vs-Asian |
8.265400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.31630001027384E-09 |
| Normal-vs-Female |
3.46170000442569E-08 |
| Male-vs-Female |
8.126200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.978000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.96189999970942E-07 |
| Normal-vs-Age(61-80Yrs) |
1.09800002423555E-09 |
| Normal-vs-Age(81-100Yrs) |
8.166100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.721000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.542800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.490400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.132400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.139600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.527000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.554200E-02 |
| Normal-vs-Grade 2 |
3.1218999996252E-07 |
| Normal-vs-Grade 3 |
4.00380000042944E-07 |
| Normal-vs-Grade 4 |
5.61820000521962E-08 |
| Grade 1-vs-Grade 2 |
4.100800E-01 |
| Grade 1-vs-Grade 3 |
3.780200E-01 |
| Grade 1-vs-Grade 4 |
1.143660E-02 |
| Grade 2-vs-Grade 3 |
9.080200E-01 |
| Grade 2-vs-Grade 4 |
1.289510E-02 |
| Grade 3-vs-Grade 4 |
1.698070E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.17080000000292E-05 |
| Normal-vs-ccB subtype |
4.59119997575641E-09 |
| ccA subtype-vs-ccB subtype |
2.816400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.06130000132998E-08 |
| Normal-vs-N1 |
7.655900E-03 |
| N0-vs-N1 |
1.181430E-01 |
|
|
